瑞思迈(RMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RMD 瑞思迈

盘后交易 05-27 18:10:40 EDT

206.10

-1.88

-0.90%

盘后206.10

+0.000.00%

16:52 EDT

最高211.56	最低206.07	成交量130.57万
今开209.07	昨收207.98	日振幅2.64%
总市值298.96亿	流通市值298.96亿	总股本1.45亿
成交额2.71亿	换手率0.90%	流通股本1.45亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RMD","market":"US","secType":"STK","nameCN":"瑞思迈","latestPrice":206.1,"timestamp":1779912000000,"preClose":207.98,"halted":0,"volume":1305684,"hourTrading":{"tag":"盘后","latestPrice":206.1,"preClose":206.1,"latestTime":"16:52 EDT","volume":17100,"amount":3524310,"timestamp":1779915163235,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.009039330704875448,"floatShares":145056384,"shares":145056384,"eps":10.370449,"marketStatus":"盘后交易","change":-1.88,"latestTime":"05-27 18:10:40 EDT","open":209.07,"high":211.56,"low":206.065,"amount":270942578.23788,"amplitude":0.026421,"askPrice":210.09,"askSize":14,"bidPrice":205,"bidSize":3,"shortable":3,"etf":0,"ttmEps":10.370449,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1779926400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":207.98,"dividendRate":0.011305,"preHourTrading":{"tag":"盘前","latestPrice":209.15,"preClose":207.98,"latestTime":"08:19 EDT","volume":848,"amount":177220.09408,"timestamp":1779884359574,"change":1.17,"changeRate":0.005626,"amplitude":0.007549},"postHourTrading":{"tag":"盘后","latestPrice":206.1,"preClose":206.1,"latestTime":"16:52 EDT","volume":17100,"amount":3524310,"timestamp":1779915163235,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.918877,"impliedVol":0.172,"impliedVolPercentile":0.0159},"requestUrl":"/m/hq/s/RMD/tweets","defaultTab":"tweets","newsList":[{"id":"1166757899","title":"财报前瞻｜瑞思迈本季度营收预计增10.39%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1166757899","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166757899?lang=zh_cn&edition=full","pubTime":"2026-04-23 09:48","pubTimestamp":1776908918,"startTime":"0","endTime":"0","summary":"瑞思迈将于2026年4月30日公布最新季度业绩，市场聚焦营收与利润增速的延续性及盈利质量变化。市场一致预期本季度瑞思迈营收为14.20亿美元，同比增长10.39%；调整后每股收益为2.80美元，同比增长18.74%；公司上季度未披露本季度明确量化指引，且目前缺乏一致口径的毛利率与净利率预测，相关指标暂未纳入。基于覆盖机构的经营模型，息税前利润预计为5.15亿美元，同比增长18.32%，反映费用效率与产品结构的持续优化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜瑞思迈本季度营收预计增10.39%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627050257","title":"瑞思迈调查：49%中国受访者认为好睡眠是长寿和健康的最重要因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2627050257","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627050257?lang=zh_cn&edition=full","pubTime":"2026-04-16 10:21","pubTimestamp":1776306106,"startTime":"0","endTime":"0","summary":"“睡眠健康正在成为越来越多中国家庭关注的长期议题。”瑞思迈（Resmed）大中华区总经理李杨阳日前在接受《中国经营报》记者采访时表示，全球84%的受访者认为持续高质量睡眠有助于延长健康寿命，不过这一认知尚未转化为实际成果。全球领先健康科技公司瑞思迈一项覆盖13个市场和地区共3万人的全球睡眠调查显示，53%的受访者每周仅有4晚或更少获得高质量睡眠。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604163707102274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4082","LU0170899867.USD","BK4585","BK4567","IE00B5TLWC47.USD","BK4588","LU2177674079.SGD","BK4504","BK4548","RMD","LU2008162690.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627298283","title":"瑞思迈(RMD)盘前下跌3.91% 机构下调目标价至255美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627298283","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627298283?lang=zh_cn&edition=full","pubTime":"2026-04-15 18:17","pubTimestamp":1776248252,"startTime":"0","endTime":"0","summary":"金吾财讯 | 瑞思迈(RMD)盘前下跌3.91%，截至发稿，报221.67美元。消息面上，近日该公司董事、董事长兼首席执行官Michael·J·Farrell出售了4991股公司股票，交易金额约112.55万美金。此外，瑞穗证券分析师Anthony Petrone近期虽维持对瑞思迈的“买入”评级，但将目标价从300美元下调至255美元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/Y2FiZWYxZjczOGJiNGFjYzNlMjE4NjgxMTg3ODM4OTg=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Y2FiZWYxZjczOGJiNGFjYzNlMjE4NjgxMTg3ODM4OTg=.png"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299235","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","UUP","UDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627470966","title":"瑞思迈新一代持续正压通气治疗机在中国大陆上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2627470966","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627470966?lang=zh_cn&edition=full","pubTime":"2026-04-15 12:51","pubTimestamp":1776228668,"startTime":"0","endTime":"0","summary":"南方财经4月15日电，记者获悉，专注于家庭睡眠、呼吸及护理的全球领先健康科技公司瑞思迈（Resmed）今日宣布新一代持续正压通气治疗机（CPAP）AirSense11正式在中国大陆上市。据介绍，全新AirSense11是瑞思迈迄今最具创新性的睡眠呼吸机产品之一，致力于为中国用户带来“看起来简单，用起来更简单”的全新智慧体验，通过“五维智慧升级”，从设计到智控全面进化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705709727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4548","BK4567","IPOS","BK4082","BK4504","LU2177674079.SGD","BK4588","RMD","LU0170899867.USD","IE00B5TLWC47.USD","BK4585","LU2008162690.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174597154","title":"异动解读 | 获杰富瑞及加拿大皇家银行上调目标价，瑞思迈盘前大涨6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174597154","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174597154?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:36","pubTimestamp":1769773015,"startTime":"0","endTime":"0","summary":"瑞思迈(RMD)今日盘前股价大幅上涨6.36%，引起了市场的关注。消息面上，两家知名投行同日上调了该公司的目标价。杰富瑞将瑞思迈的目标价从285美元上调至290美元。与此同时，加拿大皇家银行也将目标价从311美元上调至314美元。分析师上调目标价通常被视为对公司未来业绩和前景的积极看法，这可能是推动股价在盘前交易时段走强的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189356700","title":"异动解读 | 瑞思迈盘后大涨5.61%，季度利润超预期推动股价飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=1189356700","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189356700?lang=zh_cn&edition=full","pubTime":"2026-01-30 07:03","pubTimestamp":1769727830,"startTime":"0","endTime":"0","summary":"瑞思迈今日盘后股价大幅上涨5.61%，引起了市场的广泛关注。消息面上，瑞思迈公布的2026财年第二季度财务业绩表现强劲，其利润超出华尔街预期。该公司营收同比增长11%，达到14.2亿美元，调整后每股利润为2.81美元，高于市场预期的2.72美元。公司首席执行官米克·法雷尔表示，随着进入2026财年下半年，瑞思迈将继续投资创新、扩大数字健康能力并拓展全球市场，以实现可持续的盈利性增长。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131224785","title":"瑞思迈获得FDA批准，推出个性化治疗舒适设置，市场名称为Smart Comfort，这是一款AI驱动的数字医疗设备，帮助个性化CPAP治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1131224785","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131224785?lang=zh_cn&edition=full","pubTime":"2025-12-08 22:07","pubTimestamp":1765202862,"startTime":"0","endTime":"0","summary":"瑞思迈获得FDA批准，推出个性化治疗舒适设置，市场名称为Smart Comfort，这是一款AI驱动的数字医疗设备，帮助个性化CPAP治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4548","BK4585","IE00B5TLWC47.USD","BK4504","LU0170899867.USD","BK4567","BK4588","LU2008162690.USD","RMD","LU2177674079.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517887942","title":"瑞思迈盘中异动 临近午盘大幅下挫5.00%报219.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517887942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517887942?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:50","pubTimestamp":1741193455,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时50分，瑞思迈股票出现异动，股价急速跳水5.00%。截至发稿，该股报219.92美元/股，成交量44.8975万股，换手率0.31%，振幅3.42%。机构评级方面，在所有28家参与评级的机构中，64%的券商给予买入建议，32%的券商给予持有建议，4%的券商给予卖出建议。瑞思迈股票所在的医疗设备行业中，整体跌幅为0.35%。瑞思迈公司简介：瑞思迈是全球最大的呼吸护理设备公司之一，主要开发和供应用于治疗睡眠呼吸暂停的气流发生器、面罩和配件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306005056abe9dade&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306005056abe9dade&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4082","BK4585","LU2177674079.SGD","BK4567","LU2008162690.USD","BK4588","BK4504","RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517949213","title":"花旗：上调ResMed(RMD.US)评级，由中性调整至买入评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517949213","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517949213?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:12","pubTimestamp":1741191126,"startTime":"0","endTime":"0","summary":"花旗：上调ResMed(RMD.US)评级，由中性调整至买入评级。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06001248550397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507964573","title":"Piper Sandler：维持ResMed(RMD.US)评级，由中性调整至中性评级, 目标价由252.00美元调整至260.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507964573","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507964573?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:42","pubTimestamp":1738338122,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持ResMed(RMD.US)评级，由中性调整至中性评级, 目标价由252.00美元调整至260.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/31234247922297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507966535","title":"瑞思迈盘中异动 快速下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507966535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507966535?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:34","pubTimestamp":1738334059,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时34分，瑞思迈股票出现异动，股价大幅下跌5.23%。机构评级方面，在所有28家参与评级的机构中，68%的券商给予买入建议，29%的券商给予持有建议，3%的券商给予卖出建议。瑞思迈股票所在的医疗设备行业中，整体跌幅为0.27%。最近的发展和收购都集中在数字健康上，因为瑞思迈的目标是通过提供临床数据供院外环境中的患者、医疗保健顾问和付款人使用来实现差异化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223419abbe3c2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223419abbe3c2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RMD","LU2177674079.SGD","BK4585","BK4548","BK4082","BK4504","LU2008162690.USD","BK4588","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146101037","title":"ResMed 2025第二季度调整后每股收益2.43美元，高于预期2.32美元，销售额为12.8亿美元，高于预期12.7亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146101037","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146101037?lang=zh_cn&edition=full","pubTime":"2025-01-31 05:08","pubTimestamp":1738271326,"startTime":"0","endTime":"0","summary":"ResMed报告称，其季度每股收益为2.43美元，较分析师预期的2.32美元高出4.74％。与去年同期的每股收益1.88美元相比，这一数字增加了29.26％。以上内容来自Benzinga Earnings专栏，原文如下：ResMed  reported quarterly earnings of $2.43 per share which beat the analyst consensus estimate of $2.32 by 4.74 percent. This is a 29.26 percent increase over earnings of $1.88 per share from the same period last year.  The company reported quarterly sales of $1.28 billion which beat the analyst consensus estimate of $1.27 billion by 1.15 percent.  This is a 10.23 percent increase over","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ResMed 2025第二季度调整后每股收益2.43美元，高于预期2.32美元，销售额为12.8亿美元，高于预期12.7亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502634718","title":"ResMed获Piper Sandler首次覆盖","url":"https://stock-news.laohu8.com/highlight/detail?id=2502634718","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502634718?lang=zh_cn&edition=full","pubTime":"2025-01-10 20:45","pubTimestamp":1736513154,"startTime":"0","endTime":"0","summary":"ResMed(RMD.US)获Piper Sandler首次覆盖，给予中性评级,目标价252.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110210649aba5edfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110210649aba5edfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4504","BK4567","LU2008162690.USD","RMD","BK4548","LU2177674079.SGD","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494820762","title":"瑞思迈：构建数字健康生态系统 全球龙头有望继续发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2494820762","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494820762?lang=zh_cn&edition=full","pubTime":"2024-12-27 00:00","pubTimestamp":1735228800,"startTime":"0","endTime":"0","summary":"Frost & Sullivan 数据显示，随着老龄化和空气污染的加剧，全球呼吸及睡眠相关疾病的患者数在持续增加。公司为家用无创呼吸机全球领导者。公司积极构筑数字健康生态系统，提升患者体验并实现降本增效。我们认为，公司通过整合软件服务产品和呼吸健康医疗器械，搭建数字健康生态系统，有望推动设备、面罩及其他耗材收入实现良好增长态势。风险政策风险，知识产权风险，竞争加剧风险，海外经营风险，产品召回风险，商誉减值风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227151132ab946c80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227151132ab946c80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","RMD","BK4588","LU2008162690.USD","BK4585","LU2177674079.SGD","BK4548","BK4504","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493646197","title":"瑞思迈盘中异动 早盘快速下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493646197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493646197?lang=zh_cn&edition=full","pubTime":"2024-12-23 23:19","pubTimestamp":1734967168,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日23时19分，瑞思迈股票出现异动，股价急速跳水5.15%。截至发稿，该股报225.04美元/股，成交量20.3173万股，换手率0.14%，振幅2.74%。机构评级方面，在所有24家参与评级的机构中，63%的券商给予买入建议，33%的券商给予持有建议，4%的券商给予卖出建议。瑞思迈股票所在的医疗设备行业中，整体跌幅为0.46%。瑞思迈公司简介：瑞思迈是全球最大的呼吸护理设备公司之一，主要开发和供应用于治疗睡眠呼吸暂停的气流发生器、面罩和配件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122323192995eadcd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122323192995eadcd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","RMD","BK4082","BK4585","LU2177674079.SGD","BK4504","LU2008162690.USD","BK4567","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492715492","title":"瑞思迈盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492715492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492715492?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:56","pubTimestamp":1734555375,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时56分，瑞思迈股票出现异动，股价大幅跳水5.06%。截至发稿，该股报230.34美元/股，成交量56.3474万股，换手率0.38%，振幅3.95%。最近的财报数据显示，该股实现营业收入12.25亿美元，净利润3.11亿美元，每股收益2.12美元，毛利7.06亿美元，市盈率30.59倍。瑞思迈股票所在的医疗设备行业中，整体跌幅为2.30%。瑞思迈公司简介：瑞思迈是全球最大的呼吸护理设备公司之一，主要开发和供应用于治疗睡眠呼吸暂停的气流发生器、面罩和配件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904561595ea5b7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904561595ea5b7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4567","RMD","LU2177674079.SGD","BK4588","LU2008162690.USD","BK4548","BK4504","BK4585","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479436951","title":"瑞思迈2024财年第三财季实现净利润3.11亿美元，同比增加42.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479436951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479436951?lang=zh_cn&edition=full","pubTime":"2024-10-29 00:00","pubTimestamp":1730131240,"startTime":"0","endTime":"0","summary":"10月29日，瑞思迈公布财报，公告显示公司2024财年第三财季净利润为3.11亿美元，同比增加42.01%；其中营业收入为12.25亿美元，同比增加11.16%，每股基本收益为2.12美元。从资产负债表来看，瑞思迈总负债20.27亿美元，其中短期债务38.17百万美元，资产负债比为3.57，流动比率为2.93。机构评级：截至2024年10月29日，当前有17家机构对瑞思迈目标价做出预测，其中目标均价为259.10美元，其中最低目标价为190.00美元，最高目标价为283.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029000047ab7c0e17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029000047ab7c0e17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167058785","title":"异动解读 | 瑞思迈业绩超预期推动股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1167058785","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167058785?lang=zh_cn&edition=full","pubTime":"2024-10-26 05:04","pubTimestamp":1729890270,"startTime":"0","endTime":"0","summary":"瑞思迈公司在2024财年第一季度释放了喜人的业绩,推动股价在10月25日盘中大涨8.85%。总收入同比增长11%至12.2亿美元,也高于市场预期。受超预期业绩和光明长期前景的提振,市场最新预期瑞思迈2025财年每股收益将达到9.25美元,营收将达到50.85亿美元。分析师也上调了对该股的目标价,中位数为262.39美元,较此前上涨近5%,进一步反映出市场对瑞思迈未来发展的乐观预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197003552","title":"异动解读 | 瑞思迈业绩超预期推动股价大涨 睡眠呼吸设备前景广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=1197003552","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197003552?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:33","pubTimestamp":1729863228,"startTime":"0","endTime":"0","summary":"股票代码RMD,瑞思迈医疗公司今日股价盘中大涨8.63%,引起市场广泛关注。该佳绩主要得益于公司旗下用于治疗睡眠呼吸暂停的设备及相关面罩产品组合需求强劲。分析师预计,未来即便市场环境发生变化,瑞思迈在无创睡眠呼吸暂停治疗领域的产品销量依然将保持旺盛态势。受超预期业绩和光明长期前景的提振,市场最新预期瑞思迈2025财年每股收益将达到9.25美元,营收将达到50.85亿美元。这进一步反映出市场对瑞思迈未来发展的乐观预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2478933143","title":"瑞思迈盘中异动 早盘急速拉升8.20%报258.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478933143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478933143?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863110,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分，瑞思迈股票出现异动，股价快速拉升8.20%。截至发稿，该股报258.66美元/股，成交量8.985万股，换手率0.06%，振幅2.88%。瑞思迈股票所在的医疗设备行业中，整体涨幅为0.52%。其相关个股中，瑞思迈、艾利科技、Nyxoah Sa涨幅较大，Predictive Oncology Inc.、Bionano Genomics, Inc.、登士柏较为活跃，换手率分别为0.12%、0.11%、0.08%，振幅较大的相关个股有Zentek Ltd.、Avantor, Inc.、瑞思迈，振幅分别为5.14%、2.94%、2.88%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521315195bd58d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521315195bd58d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4585","BK4567","BK4588","LU2177674079.SGD","BK4504","BK4548","RMD","LU2008162690.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.resmed.com","stockEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":-0.054},{"period":"3month","weight":-0.1764},{"period":"6month","weight":-0.1845},{"period":"1year","weight":-0.1436},{"period":"ytd","weight":-0.1365}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0513},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1043},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ResMed Inc.是一家特拉华州公司，成立于1994年3月。该公司在医疗设备和基于云的软件应用程序的开发、制造、分销和营销方面处于全球领先地位，这些应用程序诊断、治疗和管理呼吸系统疾病，包括睡眠呼吸障碍、慢性阻塞性肺病、神经肌肉疾病和其他慢性疾病。该公司的产品和解决方案旨在改善患者的生活质量，减少慢性病的影响，并降低医疗保健成本，因为全球医疗保健系统继续推动从医院到家庭和低成本环境的护理转移。该公司基于云的数字软件健康应用程序以及设备旨在提供联网护理，以改善患者的治疗效果并提高客户的效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.709677,"avgChangeRate":0.025332},{"month":2,"riseRate":0.516129,"avgChangeRate":0.002251},{"month":3,"riseRate":0.580645,"avgChangeRate":0.012701},{"month":4,"riseRate":0.548387,"avgChangeRate":0.014374},{"month":5,"riseRate":0.612903,"avgChangeRate":0.011522},{"month":6,"riseRate":0.689655,"avgChangeRate":0.041106},{"month":7,"riseRate":0.733333,"avgChangeRate":0.027973},{"month":8,"riseRate":0.612903,"avgChangeRate":0.02906},{"month":9,"riseRate":0.387097,"avgChangeRate":0.015614},{"month":10,"riseRate":0.387097,"avgChangeRate":-0.004331},{"month":11,"riseRate":0.774194,"avgChangeRate":0.034364},{"month":12,"riseRate":0.580645,"avgChangeRate":0.018091}],"exchange":"NYSE","name":"瑞思迈","nameEN":"ResMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞思迈(RMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞思迈(RMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞思迈,RMD,瑞思迈股票,瑞思迈股票老虎,瑞思迈股票老虎国际,瑞思迈行情,瑞思迈股票行情,瑞思迈股价,瑞思迈股市,瑞思迈股票价格,瑞思迈股票交易,瑞思迈股票购买,瑞思迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞思迈(RMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞思迈(RMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}